NCT06133166

A Study for the Treatment of Dry Eye in Postmenopausal Women

A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of EG017 Ointment for the Treatment of Dry Eye in Postmenopausal Women

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 240 (estimated)
• Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. · Industry
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of EG017 Ointment for the Treatment of Dry Eye in Postmenopausal Women

Detailed description

To evaluate the efficacy and safety of EG017 ointment for the treatment of DED in postmenopausal women

Conditions

• Postmenopausal Women With DED

Interventions

Type	Name	Description
DRUG	EG017 ointment	Apply once a night on the skin side of both eyelids at bedtime, approximately 100 mg/eye per dose, for 8 weeks
DRUG	EG017 ointment placebo	Apply once a night on the skin side of both eyelids at bedtime, approximately 100 mg/eye per dose, for 8 weeks

Timeline

• Start date: 2023-09-20
• Primary completion: 2024-05-31
• Completion: 2024-08-09
• First posted: 2023-11-15
• Last updated: 2023-11-18

Locations

1 site across 1 country: China